INSUBCONTINENT EXCLUSIVE:
New Delhi: With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which
Serum Institute that is manufacturing the shots here.Once the UK drug regulator gives its approval to the Oxford vaccine, the expert
underway, while Pfizer is yet to make a presentation."Going by this, Oxford vaccine 'Covishield' is likely to be the first to be rolled out
emergency use authorisation for their COVID-19 vaccines early this month.The subject expert committee (SEC) on COVID-19 of the Central Drugs
Biotech after deliberating upon their applications.The application by the Indian arm of US pharmaceutical firm Pfizer was not taken up for
approved by several countries including the UK, the US, and Bahrain.While considering SII's application, the SEC had recommended that the
the UK and India, along with the outcome of the assessment of the UK Medicines and Healthcare products Regulatory Agency (MHRA) for grant of
EUA.As for Hyderabad-based Bharat Biotech, "after detailed deliberation, the committee recommended that the firm should present the safety
DCGI, officials recently had said.
